Forum › Stacking & Switching

Transitioning from GLP-1 or stacking with Elora?

4 replies5 peopleNov 1, 2026☆ Follow
Summary

Should I stay on my GLP-1 until it plateaus then switch to Elora, or is stacking better for maintenance?

Users report mostly stacking Elora with tirzepatide or retatrutide instead of switching outright, since the amylin pathway offers a different mechanism that can help break stalls or support upkeep. One approach mentioned is continuing the current GLP-1 while it remains effective rather than adding or changing early. Several people describe their own multi-drug regimens involving tirz, reta, cagrilintide, and semaglutide at varying intervals and doses, with the rationale that receptor load stays manageable even when pathways overlap.

What this discussion establishesWhere people disagree

null

Still open

Long-term outcomes and optimal dosing when combining or switching these agents

Nothing here is advice.

4 replies · 5 people
WarmKettle86archiveopening postNov 1

I'd like opinions on Elora. Not using it currently, the plan has been to keep going with the GLP-1 until it loses effectiveness or reaches a plateau, then move to Elora for simpler long-term upkeep. Is this reasonable thinking or does it have flaws? Has anyone quit their GLP-1 and moved to Elora instead? If so, what dose were they on before, what starting dose of Elora, and how did the change work out? Also noticing some people microdose or combine Elora with Tirz or Reta. What's the view on that, how are others dosing it, and what results have shown up?

SteadyLantern35archiveNov 1

Using 4 mg tirz together with 1 mg Elora for upkeep, though only fifteen days so far and therefore no extended view yet.

WarmMeadow92archiveNov 1
↳ replying to @WarmKettle86 (opening post)

Most seem to combine eloralintide with tirz or reta rather than taking it by itself. One user is said to be on elora alone. It looks like elora fits best as an add-on to a glp1 to get past a stall or support upkeep when paired with something else, given the separate pathway. It could also suit cases where tirz or reta fail to work or produce too many sides. The plan to stay on the current glp1 sounds solid. If appetite stays down, weight keeps dropping, and sides remain tolerable then there is no reason to add or switch to elora.

GreyLantern71archiveNov 1

Not on Elora but using Cagri, another amylin agent. Favor combining and would not replace one with the other because they act on separate pathways. Dosing 10 mg Tirz on Thursday along with 0.5 mg each of Cagri and Sema on Monday.

GreyLedger42archiveNov 2
↳ replying to @GreyLantern71

Also stack in a similar way except with 5 mg Tirz every six days and 6 mg Reta every six days, spacing them three days apart, plus 1.5 mg Cagri each Sunday. Before any criticism, this follows coming off 15 mg Tirz so the receptor load stays lower even with overlapping pathways.

Related discussions

Add your experience

If you have tried it, this topic is still open. Sign in to reply — it takes a minute.